Win for Equality As New York State Caste Bills Targeting American Hindus Fail To Advance

05-06-2026 19:27 via prnewswire.com

Win for Equality As New York State Caste Bills Targeting American Hindus Fail To Advance

Bills introduced in 2025 and 2026 lacked facial neutrality and furthered colonial stereotypes ALBANY, N.Y., June 5, 2026 /PRNewswire/ -- The Coalition of Hindus of North America (CoHNA) is pleased that New York Senate Bill S.6531 and House Bill A.6920 did not advance this legislative...

Read more »

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit

Philippine Airlines to Join oneworld Alliance

Philippine Airlines to Join oneworld Alliance

Ramtech VP of Business Development Kelly Williams to Speak on Modular Construction Benefits in Panel Discussion at 2026 InterFace Houston Multifamily Conference

Ramtech VP of Business Development Kelly Williams to Speak on Modular Construction Benefits in Panel Discussion at 2026 InterFace Houston Multifamily Conference

University of Phoenix researchers publish study examining doctoral students' attitudes toward AI chatbots and ChatGPT use in higher education

University of Phoenix researchers publish study examining doctoral students' attitudes toward AI chatbots and ChatGPT use in higher education

Bybit EU posiluje své postavení v Evropě před přechodem na regulaci MiCAR

Bybit EU posiluje své postavení v Evropě před přechodem na regulaci MiCAR

82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with Continuous Glucose Monitoring

82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with Continuous Glucose Monitoring

Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications

Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications

Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity

Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity

Bitmine Immersion Technologies kondigt prijsstelling aan van verhoogde aanbieding van eeuwigdurende preferente aandelen uit Serie A

Bitmine Immersion Technologies kondigt prijsstelling aan van verhoogde aanbieding van eeuwigdurende preferente aandelen uit Serie A

Bitmine Immersion Technologies gibt die Preisgestaltung für die aufgestockte Emission von unbefristeten Vorzugsaktien der Serie A bekannt

Bitmine Immersion Technologies gibt die Preisgestaltung für die aufgestockte Emission von unbefristeten Vorzugsaktien der Serie A bekannt

Bitmine Immersion Technologies annonce le prix de son offre élargie d'actions privilégiées perpétuelles de série A

Bitmine Immersion Technologies annonce le prix de son offre élargie d'actions privilégiées perpétuelles de série A

CERAVE NA PRVNÍCH CELOSVĚTOVÝCH CERAWARDS PŘIVÍTALO VÍCE NEŽ 100 OCENĚNÝCH TVŮRCŮ OBSAHU Z 22 ZEMÍ

CERAVE NA PRVNÍCH CELOSVĚTOVÝCH CERAWARDS PŘIVÍTALO VÍCE NEŽ 100 OCENĚNÝCH TVŮRCŮ OBSAHU Z 22 ZEMÍ

Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association's 2026 Scientific Sessions

Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association's 2026 Scientific Sessions

Bybit EU renforce son positionnement européen avant la transition vers le règlement MiCA

Bybit EU renforce son positionnement européen avant la transition vers le règlement MiCA